• No results found

Oral Solid Dosage Forms

N/A
N/A
Protected

Academic year: 2021

Share "Oral Solid Dosage Forms"

Copied!
6
0
0

Loading.... (view fulltext now)

Full text

(1)

Pre-conFerence coUrse

compile your own set of lessons

Fundamentals of granulation

„

Fundamentals of tabletting

„

HiGHliGHts:

Approach to continuous processes: the total line

„

Trouble-shooting in the solida production

„

Hot stage extrusion and injection moulding

„

Multiple Unit Pellet System: MUPS Tablets

„

Effervescent and Multi Layer Tablets

„

Recent developments in Rotary Tabletting

„

Compaction Simulators for Formulation Development

„

GMP Inspection of Solida-Facilities

„

Use of Low-cost Equipment made in Far East

„

News from ACHEMA Exhibition

„

barcelona, spain

26 – 27 may 2009

ECA

EUROPEANCOMPLIANCE

A

CADEMY

sPeaKers

ericH battanta

Novartis Pharma

Dr Urs FlUry

Pharmaconduct

Günter Körblein

Senior Advisor in

Pharmaceutical Technology

Dr rob lammens

Technical Services Consult

Lammens

Dr Jean-Denis mallet

Formerly Head of the French

Pharmaceutical Inspection

Department

ProF Dr Jean PaUl remon

University of Gent

Dr HaralD staHl

GEA Pharma Systems

ProF Dr KlaUs-JürGen

steFFens

University of Bonn

Dr micHel UlmscHneiDer

F. Hoffmann - La Roche

PD Dr Karl GerHarD

WaGner

Boehringer Ingelheim Pharma

Oral Solid

Dosage Forms

Manufacture – Technology –

Compliance

Oral Solid

Dosage Forms

Manufacture – Technology –

Compliance

(2)

This conference aims at informing about recent technologies in the manufacture of

oral solid dosage forms and how state-of-the art processes are to be designed to be

efficient and compliant and how trouble-shooting in production can be carried out.

Solid dosage forms are still the most common dosage form, first and foremost tablets

with a portion of over 50%. Tablets are the least expensive dosage form, have a good

stability and open up adjustable possibilities of drug release. But although tabletting

is used since 1843 there are still open questions and problems in the daily routine.

Development and production of oral solid dosage forms with optimised therapeutic

attributes is as well as the implementation of stable and cost efficient processes of

large importance. Modern techniques like compression simulation, chemical

imag-ing, NIR and multivariate data analysis can be used to overcome problems in daily

business.

Continuous processing

„

Fundamentals and expertise of tabletting and granulation

„

Trouble shooting using the multivariate approach

„

Special tablet forms

„

Adjusting release behaviour

„

Compaction simulation

„

Usage of low cost-equipment from far east

„

GMP Compliance in the Solida Factory

„

A deeper understanding of the basics of galenics of solid forms as well as detailed

expert knowledge will help to optimise the quality of daily work and during

trouble-shooting to solve production problems:

This event is designed for all managers and executives from Pharmaceutical

Devel-opment, Production and Quality Assurance, responsible for develDevel-opment, transfer

or manufacture of solid dosage forms.

Günter Körblein,

Senior Advisor in Pharmaceutical Technology

On Tuesday, 26 May 2009, you are cordially invited to a

social event. This is an excellent opportunity to share

your experiences with colleagues from other

compa-nies in a relaxed atmosphere.

objectives

background

target audience

moderator

social event

Pre-conference course

Fundamentals of tabletting

Fundamentals of Granulation

Your are an expert in tabletting, but not in granulation, or vice versa ?

Then take advantage of the Pre-Conference Course and complete your knowledge

of pharmaceutical technologies.You can choose between different lessons in

gran-ulation and compression and compile the ideal content for you. The Lessons are

designed to raise your knowledge from basic to deeper understanding.

The specific types of equipment will be discussed as well as working principles,

challenges during scale-up and trouble shooting in production environment.

Compile your own set of lessons:

Please choose three out of these six lessons; one lesson from each line

tabletting basics

or Dry Granulation basics

Granulation basics

or basics of tabletting with single stroke

Presses:

Eccentric presses, Pneumo Hydraulic

presses and Compaction Simulator

Basics of tabletting with rotary

(3)

Wet Granulation – Why and How continuous?

Introduction

„

„Continu-Phobia“ – a Pharmaceutical Phenomenon?

„

The History – Justifications and Solutions

„

Why a Continuous Hype Today – Novel Techniques

„

The Beginning – Multi-Component Supply

„

Solutions for Granulation

„

Solutions for Drying

„

Blending-in Lubricants – The Stumbling Block

„

The “Total-Line” – Approach, Fiction or Reality?

„

Conclusion

„

operating principle of various types of compaction simulators

Aspects of rotary presses to be simulated

„

Mimicking force time signals and punch movements of various rotary presses

„

Using a laboratory rotary press in formulation development and/or trouble

„

shooting

Comparing dwell time and total densification times of various rotary presses

„

Influence of speed of densification on tablet properties

„

Recognizing problems related to densification speed early in development

Using tensile strength and tablet porosity instead of hardness and compaction

force

Instrumenting compaction simulators

„

Requirements to precision and accuracy of force and displacement

measure-−

ments

Ejection force, Residual force, Take off force

Measurement examples

Determining deformation behaviour of API’s/powders from Heckel Plots

Solving problems related to

„

Capping, laminating, sticking

Adhesion upon bilayer tabletting

Simulated and real “Force-Time-Profiles” of selected rotary presses

„

Comparing “Force-Hardness-Profiles” from a simulator and selected rotary presses

„

Influence of punch format on tablet properties

„

Containment, WIP/CIP aspects

„

Data-analysis for Process Understanding: multivariate approach

Added value of data-analysis & chemometrics

„

Measuring techniques for use in trouble shooting and root cause investigations

„

Short introduction to NIR

„

PCA – Principle Component Analysis

„

Chemical Imaging

„

Data-mining

„

Examples of applications

„

Identification & qualification of raw materials

Assessing dissolution issues

Evaluation and use of data

recent developments in rotary tabletting

Features of recent tablet presses

„

Tooling

Containment

New Force Feeder

Latest Developments and Highlights from ACHEMA Exhibition

„

multiple Unit Pellet system: mUPs tablets – Principles, Processes, limits

Formulation principles

„

Influence of compression on the release characteristics of coated pellets

„

Distribution and deformation of pellets within the tablet matrix

„

Minimising of film damages

„

Uniformity of content and mass

„

Fraction and seize of single units and their influence on tablet and mixture

„

characteristics

(4)

effervescent and multi layer tablets

Challenges and solutions when manufacturing effervescent tablets

„

External lubrication

„

Challenges and solutions when manufacturing multi layer tablets

„

Machine concepts for the manufacturing of multi layer tablets

„

In depth discussion of the Bi layer compression cycle

„

Control and monitoring during compression of multi layer tablets

„

Hot stage extrusion and injection moulding

Introduction

„

Process

Materials

Formulation design

„

Oral drug delivery

Trans-drug delivery

Implants

Conclusion

„

low-cost equipment made in Far east - experiences from engineering and

operation

Presentation of low cost manufacturing and equipment sourcing strategy of a global

pharmaceutical company based on solid dosage forms. The example will be based

on two new sites in Singapore and India from Novartis. Further different operational

strategies will be analysed as well as evaluation criteria for equipment selections.

Finally execution success factors will be discussed.

Pharmaceutical production for solid dosage forms

„

Low Cost manufacturing strategic

„

Evaluation criteria for equipment sourcing

„

Cost comparison

„

Example of execution issues

„

inspection of solida-Facilities

(Oral) Solid Dosage Forms : a differentiated picture, from powders to soft capsules

„

Identification of main risks linked with the production of Oral Solid Dosage forms

„

Specific Regulatory requirements related to solida manufacturing

„

Some typical points assessed during solida facilities inspections

„

Case studies and most frequent deviations observed

„

Conclusion

„

ericH battanta, Novartis Pharma AG

Erich Battanta has a master in process engineering from the ETH Zürich. His career in Novartis began in 1996 in the engineering department where he was involved as Project Engineer and later as Project before becoming the Project Manager for a new production facility in Grimsby. Afterwards he became Project Manager for a new green field solid dosage facility in Singa-pore. Currently he is Head of Engineering ChemOps responsible for Engineering and capital investments within global chemical operations of Novartis.

Programme (cont.)

speakers

low cost equipment traditional equipment

Images: Novar

(5)

Dr Urs FlUry, Pharmaconduct GmbH

Urs Flury has a master degree in Microbiology/Biochemistry and a PhD degree in Natural Science He started his career at Sandoz in the global pharmaceutical production department as Project Leader where he was involved in the launches of new pharmaceutical products and introduction of new technologies. Afterwards he became Head of Pharmaceutical Pro-duction Department for Solid Dosage Forms at the Site Stein (CH) of Novartis Pharma. Later on, as Head of Manufacturing Standards & Technology in Global Technical Operations, he developed new Global Manufacturing Strategies for Drug Products. Since 2008 he runs his own business as consultant.

Günter Körblein, Senior Advisor in Pharmaceutical Technology

Günter Körblein has a degree in Mechanical Engineering. He started his career at Pharma Consult in 1971 and joined Roha Arzneimittel some years later. He worked for Sandoz Pharma in Basel as Head of Divisional Engineering. He joined Boehringer Ingelheim afterwards as Head of Corporate Division Technology and finally worked for Uhde were he was Director Marketing Uhde-Pharma. Now he works as Senior Consultant for the German Government and the United Nations.

Dr rob lammens, Technical Services Consult Lammens

Dr Lammens studied Physical Chemistry and performed his PhD in Pharmaceutical Technol-ogy, before he joined the Pharmaceutical Technology Department of Bayer AG at Leverkusen in 1981. Since 2001 he is a senior lecturer at the Pharmaceutical Technology Department of the University of Bonn and is running the company Technical Services Consult Lammens.

Dr Jean-Denis mallet, Formerly Head of the French Pharmaceutical Inspection Department

Jean-Denis Mallet is a doctor pharmacist, graduated in technological pharmacy (IPI) and management (ISMA). He is currently a GMP auditor within the International Committee of the Red Cross (ICRC). He was previously the Head of the Pharmaceutical Inspection Department at the French Health Products Regulatory Agency (Afssaps). He also used to work in or with the pharmaceutical industry during 12 years at various positions including QA, Production Management, Engineering and GMP Consulting.

ProF Dr Jean PaUl remon, University of Gent

Prof. Dr. Jean Paul Remon is professor of Pharmaceutical Technology at the Faculty of Pharma-ceutical Sciences of Ghent University. He has been Dean of the Faculty and Chairman of the Department of Pharmaceutics since 1997. He is co-author of more than 320 international publications and 17 patent/patent applications. The main field of research is solid dosage forms more specifically: wet granulation, pelletilisation, hot stage extrusion, spray drying, nasal powder delivery and veterinary dosage forms.

ProF. Dr. KlaUs-JürGen steFFens, University of Bonn

Prof.. Steffens holds a chair in Pharmaceutical Technology at the University of Bonn. He is an expert in the development and production of solid dosage forms. The physicochemical char-acterization of raw materials and final products is one of his most important research fields with more than 20 years experience in special analytical tools, among them spectroscopic methods like NIRS and XRD.

Dr HaralD staHl, GEA Pharma Systems

Dr Harald Stahl worked the Pharmaceutical Development of Schering AG in Germany, where worked on the the aseptic production of pellets. Since 1995 he served within GEA Process Technology in various positions. Presently he owns the position of a Senior Pharmaceutical Technologist of GEA Pharma Systems. He has published more than 20 papers on various aspects of pharmaceutical production.

Dr micHel UlmscHneiDer, F. Hoffmann - La Roche AG

Michel Ulmschneider graduated in physical chemistry and is member of the PAT and analyti-cal business process group in Basel. He has been at the forefront of the development of quantitative near-infrared spectroscopic methods. His extensive experience in the field of NIR and chemometrics led him to habilitate ate the University de Haute-Alsace in 2000.

PD Dr Karl GerHarD WaGner, Boehringer Ingelheim Pharma GmbH & Co. KG

Karl G. Wagner studied pharmacy and gained his PhD in pharmaceutical technology. After an academic scholarship at the University of Texas he worked at the University of Tübingen at the institute for pharmaceutical technology. After his postdoctoral lecture qualification he joined Boehringer Ingelheim in Biberach and became head of the laboratory for galenic research, modified release. He still holds the position of an external lecturer at the University of Tübingen with the main research on modified release dosage forms.

(6)

Date Pre-conference course

Tuesday, 26 May 2009, 09.00 – 12.30 h (Registration and coffee 08.30 – 09.00 h)

Date conference

Tuesday, 26 May 2009, 13.30 – 18.30 h (Registration and coffee 13.00-13.30 h) Wednesday, 27 May 2009, 08.30 – 15.30 h Venue nh-Hotel Constanza C/Deu i Mata, 66-69 08029 Barcelona, Spain Tel +34 93 2811500, Fax +34 93 4100335

Fees Pre-conference course & conference

Non-ECA Members EUR 1,890,- per delegate plus VAT ECA Members EUR 1,700.- per delegate plus VAT APIC Members EUR 1,795.- per delegate plus VAT (does not include ECA Membership)

EU GMP Inspectorates EUR 945.- per delegate plus VAT

The conference fee is payable in advance after receipt of invoice and includes conference documentation, dinner on the first day, lunch on both days and all refreshments. VAT is reclaimable.

Fees conference

Non-ECA Members EUR 1,490.- per delegate plus VAT ECA Members EUR 1,340.- per delegate plus VAT APIC Members EUR 1,415.- per delegate plus VAT (does not include ECA Membership)

EU GMP Inspectorates EUR 745.- per delegate plus VAT

The conference fee is payable in advance after receipt of

invoice and includes conference documentation, dinner on the first day, lunch on the second day and all refreshments. VAT is reclaimable.

accommodation

CONCEPT HEIDELBERG has reserved a limited number of rooms in the conference hotel. You will receive a room reservation form when you have registered for the conference. Please use this form for your room reservation or be sure to mention "VA 6040 ECA Event" to receive the specially negotiated rate for the duration of your stay. Reservation should be made directly with the hotel not later than 14 April 2009. Early reservation is recommended.

conference language

The official conference language will be English.

organisation and contact

ECA has entrusted Concept Heidelberg with the organisation of this event. CONCEPT HEIDELBERG P.O. Box 10 17 64 69007 Heidelberg, GERMANY Phone +49 (0) 62 21/84 44-0 Fax +49 (0) 62 21/84 44 34 E-mail: [email protected] www.concept-heidelberg.de

For questions regarding content:

Dr Robert Eicher (Operations Director) at +49-62 21/ 84 44 12 or per e-mail at [email protected].

For questions regarding reservation, hotel, organisation etc.:

Ms Marion Weidemaier (Organisation Manager) at +49-62 21/ 84 44 46 or per e-mail at [email protected].

Reservation Form (Please complete in full)

oral solid Dosage Forms,

26 – 27 May 2009, Barcelona, Spain

*

optional Pre-conference course on 26 May 2009: Please choose three out of the

six lessons; one lesson from each line

*

Tabletting Basics or

*

Dry Granulation Basics

*

Granulation Basics or

*

Basics of Tabletting with Single Stroke Presses

*

Tabletting with Rotary Tablet Presses or

*

Basics of Wet Granulation

*

Mr

*

Ms

Title, first name, surname Company

Department

important: Please indicate your company’s Vat iD number Purchase order number, if applicable

Street / P.O. Box

City Zip Code Country

Phone / Fax E-Mail (Please fill in)

If the bill-to-address deviates from the specification to the right, please fill out here:

CONCEPT HEIDELBERG P.O. Box 10 17 64

Fax +49 (0) 6221/84 44 34 69007 Heidelberg Germany

General terms and conditions

If you cannot attend the conference you have two options: 1. We are happy to welcome a substitute colleague at any time.

2. If you have to cancel entirely we must charge the following processing fees: Cancellation  until 2 weeks prior to the conference 10 %,

 until 1 weeks prior to the conference 50 %  within 1 week prior to the conference 100 %.

CONCEPT HEIDELBERG reserves the right to change the materials, instructors, or speakers without notice or to cancel an event. If the event must be cancelled, registrants will be notified as soon as

possible and will receive a full refund of fees paid. CONCEPT HEIDELBERGwill not be responsible for discount airfare penalties or other costs incurred due to a cancellation.

terms of payment: Payable without deductions within 10 days after receipt of invoice. important: This is a binding registration and above fees are due in case of cancellation or

non-appearance. If you cannot take part, you have to inform us in writing. The cancellation fee will then be calculated according to the point of time at which we receive your message. In case you do not appear at the event without having informed us, you will have to pay the full registration fee, even if you have not made the payment yet. Only after we have received your payment, you are entitled to participate in the conference (receipt of payment will not be confirmed)!

easy registration

reservation Form: concePt HeiDelberG P.o. box 10 17 64 69007 Heidelberg Germany

reservation Form:

+ 49 6221 84 44 34

@

e-mail:[email protected]

internet:www.gmp-compliance.org

+49 6221 84 44 34

wh/vers.

References

Related documents

fast ginning genotypes as a group had lower fiber strength, fiber length, nep size, nep number, SFC, and higher fineness than the high energy, low ginner rate group (Table 5).

AC: Ameroid constrictor; AMI: Acute myocardial infarction; CAD: Coronary artery disease; CAG: Coronary angiography; CI: Cryoinjury; DAPI: 4',6- diamidino-2-phenylindole

Prior injection of exosomes loaded with siRNA against Cltc could significantly block the endocytic function of the MPS in the spleen and liver, and thus significantly

The new Section 6035(a) requires that, within 30 days of filing an estate tax return (or 30 days of the due date in the case of a late return) the executor of any estate required to

The study hence focused on non-parametric regression methods which include Kernel and Cubic spline smoothing techniques which were applied on maternal health care

Table 4: Traverse control points (Elevations determined using Digital Level).. TESTS AND RESULTS 4.1 Total station Test

The application to a protein interaction network in Section 4.3 tests the model on a real data set where we expect a noisy, vague latent block structure to inform the

Bernardo 1979 proposed a procedure to produce reference priors by maximizing the expected information about the parameters provided by independent replications of an experiment